Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Qomel CoSAU:9600 20 EV-to-EBITDA is 16.81 as of Sep. 21, 2026, which is 9% above its 10-year median of 15.44. GuruFocus rates SAU:9600 with a GF Score™ of 20/100. The stock has 3 warning signs investors should review. Among 523 Healthcare Providers & Services companies, Qomel Co ranks better than 53.15% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Qomel Co's enterprise value is ﷼276.9 Mil.
Qomel Co's EBITDA for the trailing twelve months (TTM) ended in Jun. 2026 was ﷼16.5 Mil. Therefore, Qomel Co's EV-to-EBITDA for today is 16.81.
The historical rank and industry rank for Qomel Co's EV-to-EBITDA or its related term are showing as below:
SAU:9600'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 9.4 Med: 15.44 Max: 22.76
Current: 9.47
During the past 5 years, the highest EV-to-EBITDA of Qomel Co was 22.76. The lowest was 9.40. And the median was 15.44.
SAU:9600's EV-to-EBITDA is ranked better than 53.15% of 523
companies
in the Healthcare Providers & Services industry
Industry Median: 10.09
vs SAU:9600: 9.47
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Qomel Co's share price for today is ﷼37.00.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Qomel Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 was ﷼2.137.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
The historical data trend for Qomel Co's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Pharmaceutical Retailers subindustry, Qomel Co's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Qomel Co EV-to-EBITDA vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Qomel Co's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Qomel Co's EV-to-EBITDA falls into.
Qomel Co's current Enterprise Value is ﷼276.9 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Qomel Co's EBITDA for the trailing twelve months (TTM) ended in Jun. 2026 was ﷼16.5 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Qomel Co (SAU:9600) has a EV-to-EBITDA of 16.81 as of Sep. 21, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Qomel Co. This is near median its historical median of 15.44. Over the past decade, Qomel Co's EV-to-EBITDA has ranged from 9.40 to 22.76. According to the industry distribution chart, Qomel Co ranks #245 out of 523 companies in the Healthcare Providers & Services industry, placing it in the top 46.8%.
Is Qomel Co's EV-to-EBITDA too high?
Qomel Co's current EV-to-EBITDA of 16.81 is near median its 10-year median of 15.44. Over the past 10 years, this metric has ranged from a low of 9.40 to a high of 22.76. The Healthcare Providers & Services industry median EV-to-EBITDA is 10.09. Qomel Co's value of 16.81 is 66.6% above this industry median. Based on the distribution chart, Qomel Co ranks #245 out of 523 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Qomel Co has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does Qomel Co's EV-to-EBITDA compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Qomel Co ranks #245 out of 523 companies for EV-to-EBITDA. This puts Qomel Co in the upper half of its industry. The industry median EV-to-EBITDA is 10.09. Qomel Co's value of 16.81 is 66.6% above this benchmark. Historically, Qomel Co's own EV-to-EBITDA has ranged from 9.40 to 22.76 over the past decade. While the company's 10-year median is 15.44 vs. the industry median of 10.09, Qomel Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Healthcare Providers & Services company?
The median EV-to-EBITDA among Healthcare Providers & Services companies is 10.09, based on 523 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Qomel Co's current EV-to-EBITDA of 16.81 is 66.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Qomel Co. For the Healthcare Providers & Services industry, the median EV-to-EBITDA is 10.09 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Qomel Co's current EV-to-EBITDA is 16.81, which is near median its own 10-year median of 15.44. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Qomel Co stock overvalued right now?
Qomel Co (SAU:9600) has a current EV-to-EBITDA of 16.81. The current EV-to-EBITDA is 16.81, which is near median its 10-year median of 15.44 and 66.6% above the Healthcare Providers & Services industry median of 10.09. Qomel Co's overall GF Score™ is 20/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Qomel Co (SAU:9600), the current EV-to-EBITDA is 16.81 as of Sep. 21, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Qomel Co is a Saudi Arabian-based healthcare company that provides high-quality medicines and innovative medical services whose core business focuses on institutional and government supply through a professional field force and an in-depth knowledge of the local business environment They offer services such as pharmaceutical and medical supplies.
20GF Score
Get the complete analysis for SAU:9600
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SAU:9600 has been successfully added to your 
